DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The "Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Atopic Dermatitis derived from epidemiological analysis, patients diagnosed with Atopic Dermatitis, and patients treated with a drug therapy.

The research study helps executives estimate Atopic Dermatitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Atopic Dermatitis prevalence, Atopic Dermatitis diagnosis rate, and Atopic Dermatitis treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report

Atopic Dermatitis Patient Flow Atopic Dermatitis Prevalence Atopic Dermatitis Diagnosed Patients Atopic Dermatitis Treated Patients

Key Topics Covered

1. Atopic Dermatitis: Disease Definition

2. Global Atopic Dermatitis Patient Flow

2A. Global Atopic Dermatitis Prevalence

2B. Global Atopic Dermatitis Diagnosed Patients

2C. Global Atopic Dermatitis Treated Patients

3. Atopic Dermatitis Patient Flow in the US

3A. Atopic Dermatitis Prevalence in the US

3B. Atopic Dermatitis Diagnosed Patients in the US

3C. Atopic Dermatitis Treated Patients in the US

4. Atopic Dermatitis Patient Flow in Europe

4A. Atopic Dermatitis Prevalence in Europe

4B. Atopic Dermatitis Diagnosed Patients in Europe

4C. Atopic Dermatitis Treated Patients in Europe

5. Atopic Dermatitis Patient Flow in Germany

5A. Atopic Dermatitis Prevalence in Germany

5B. Atopic Dermatitis Diagnosed Patients in Germany

5C. Atopic Dermatitis Treated Patients in Germany

6. Atopic Dermatitis Patient Flow in France

6A. Atopic Dermatitis Prevalence in France

6B. Atopic Dermatitis Diagnosed Patients in France

6C. Atopic Dermatitis Treated Patients in France

7. Atopic Dermatitis Patient Flow in Spain

7A. Atopic Dermatitis Prevalence in Spain

7B. Atopic Dermatitis Diagnosed Patients in Spain

7C. Atopic Dermatitis Treated Patients in Spain

8. Atopic Dermatitis Patient Flow in Italy

8A. Atopic Dermatitis Prevalence in Italy

8B. Atopic Dermatitis Diagnosed Patients in Italy

8C. Atopic Dermatitis Treated Patients in Italy

9. Atopic Dermatitis Patient Flow in UK

9A. Atopic Dermatitis Prevalence in UK

9B. Atopic Dermatitis Diagnosed Patients in UK

9C. Atopic Dermatitis Treated Patients in UK

10. Atopic Dermatitis Patient Flow in Japan

10A. Atopic Dermatitis Prevalence in Japan

10B. Atopic Dermatitis Diagnosed Patients in Japan

10C. Atopic Dermatitis Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/f43hc2/global_atopic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006187/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 04:37 PM/DISC: 06/11/2018 04:37 PM

http://www.businesswire.com/news/home/20180611006187/en